QA: Oncotelic Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000908259_2025_Oncotelic_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000908259, Oncotelic Therapeutics Inc

  xvar xval
0 AssetsCurrent 134,211
1 IntangibleAssetsNetIncludingGoodwill 2,788,230
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 23,754,985
4 LiabilitiesCurrent 19,199,914
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 387,720
9 ResearchAndDevelopmentExpense 8,806
10 remainder_Expenses 3,079,239
11 remainder_Revenues 11,933
12 remainder_NetIncome -1,320,694
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 26,677,426
1 Liabilities 19,199,914
2 Expenses 3,475,765
3 Revenues 11,933
4 StockholdersEquity 7,477,512
5 NetIncome -4,784,526
6 ComprehensiveNetIncome -4,784,526
7 BaseVar 25,342,866
8 EconomicCapitalRatiobeforeLimitedLiability 0.502
9 EconomicCapitalRatio 1.88

Edgar->Model Mapping

Feature Distribution

Change over Time